Core G: University of Kentucky Alzheimer's Disease Core Center

核心 G:肯塔基大学阿尔茨海默病核心中心

基本信息

  • 批准号:
    10261968
  • 负责人:
  • 金额:
    $ 12.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Research Education Component The Research Education Component (REC) of the UK-ADRC offers a variety of research educational activities and comprehensive, mentored research skills development programs that will enhance the development of the future workforce to meet the nation’s biomedical, behavioral, and clinical needs in Alzheimer’s disease and related dementias (ADRD) research. The REC will leverage resources within and outside the UK-ADRC to create an outstanding, multidisciplinary, and collaborative environment for training the next generation of researchers in scientific areas that parallel the theme of our ADRC (Transitions from Normal to Late-Life, Multi- Etiology Dementias), and with an emphasis on increasing representation of researchers from diverse backgrounds. We will continue to build on a long history of collaborative and dedicated faculty, a strong foundation in multidisciplinary team science, and an outstanding track record of success in mentoring and education of researchers across the training spectrum. We will also establish a new REC Scholar program aimed at junior investigators (Assistant Professors, senior research associates, or clinical fellows). This program will support junior investigators from diverse, multidisciplinary fields to pursue mentored basic, translational, or clinical research in ADRD, and follow a customized training plan to help the scholars move toward their career development goals. This training will be done in a supportive and collaborative academic environment with substantial training resources and an experienced and dedicated training faculty. Scholars will have the opportunity to learn state-of-the-art research skills in disciplines that have been identified as critically needed areas for the ADRC workforce of the future. Examples of training areas where the UK-ADRC has strong expertise include analysis of longitudinal clinical outcomes, clinical trial design, MRI imaging and novel fluid biomarkers, quantitative neuropathology and AD mimics, data analysis/ study design in mixed dementias, and health literacy and inequities. REC goals will involve interactions with all the UK-ADRC Cores and will be achieved through the following specific aims. Aim 1. Provide education programs and research skills development opportunities for investigators at UK. Aim 2. Identify, select, support, and retain REC scholars from diverse backgrounds and disciplines to engage in ADRD research. Aim 3. Develop an individualized mentoring plan and educational program for each REC scholar to enable advancement to independent research and funding in ADRD research. Aim 4. Evaluate progress of the REC scholars, address barriers towards the goal of independence in ADRD research and refine delivery of the program’s educational structure and processes. Following completion of the Program, participants will have the knowledge, expertise, and confidence to successfully pursue a long-term career in dementia research.
项目概要/摘要:研究教育部分 英国ADRC的研究教育部分(REC)提供各种研究教育活动 和全面的,指导性的研究技能发展计划,将加强发展的 未来的劳动力,以满足国家的生物医学,行为,和临床需要在阿尔茨海默病和 相关痴呆症(ADRD)研究。REC将利用UK-ADRC内外的资源, 为培养下一代创造一个杰出的,多学科的和协作的环境 在科学领域的研究人员,平行我们的ADRC的主题(从正常到晚年的过渡,多, 病因学痴呆症),并强调增加来自不同领域的研究人员的代表性 背景我们将继续建立在合作和敬业的教师,一个强大的历史 多学科团队科学的基础,以及在指导和 研究人员在整个培训范围内的教育。我们还将建立一个新的REC奖学金计划 针对初级研究者(助理教授、高级研究员或临床研究员)。这 该计划将支持来自不同,多学科领域的初级研究人员, 翻译,或临床研究在ADRD,并遵循定制的培训计划,以帮助学者移动 实现职业发展目标。这项培训将在一个支持和合作的学术 环境与大量的培训资源和经验丰富,专门的培训教师。学者 将有机会学习国家的最先进的研究技能的学科已被确定为 未来ADRC劳动力急需的领域。英国-ADRC培训领域的例子 具有很强的专业知识,包括纵向临床结局分析、临床试验设计、MRI成像和 新型液体生物标志物、定量神经病理学和AD模拟物,混合研究中的数据分析/研究设计 失智症、健康知识普及和不平等。REC目标将涉及与所有UK-ADRC核心的互动 并将通过以下具体目标来实现。 目标1.为英国的研究人员提供教育项目和研究技能发展机会。 目标2.识别,选择,支持和留住来自不同背景和学科的REC学者, 在ADRD研究中。 目标3.为每个REC学者制定个性化的指导计划和教育计划, 促进ADRD研究的独立研究和资助。 目标4。评估REC学者的进展,解决ADRD实现独立目标的障碍 研究和完善该计划的教育结构和过程的交付。 完成该计划后,参与者将拥有知识,专业知识和信心, 在痴呆症研究方面成功地追求长期的职业生涯。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LINDA J VAN ELDIK其他文献

LINDA J VAN ELDIK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LINDA J VAN ELDIK', 18)}}的其他基金

GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
治疗阿尔茨海默病的口服制剂药物的 GMP 生产和扩展毒理学
  • 批准号:
    10624841
  • 财政年份:
    2022
  • 资助金额:
    $ 12.01万
  • 项目类别:
University of Kentucky Alzheimer's Disease Research Center
肯塔基大学阿尔茨海默病研究中心
  • 批准号:
    10662314
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
Core G: University of Kentucky Alzheimer's Disease Core Center
核心 G:肯塔基大学阿尔茨海默病核心中心
  • 批准号:
    10662371
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
Core A: University of Kentucky Alzheimer's Disease Core Center
核心 A:肯塔基大学阿尔茨海默病核心中心
  • 批准号:
    10662339
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
Core A: University of Kentucky Alzheimer's Disease Core Center
核心 A:肯塔基大学阿尔茨海默病核心中心
  • 批准号:
    10459466
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
Portable and modular UDS Data Collection software to increase collaboration and engagement of Alzheimer’s Disease Research Center research software engineers
便携式模块化 UDS 数据收集软件,可增强阿尔茨海默病研究中心研究软件工程师的协作和参与
  • 批准号:
    10608722
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
Core A: University of Kentucky Alzheimer's Disease Core Center
核心 A:肯塔基大学阿尔茨海默病核心中心
  • 批准号:
    10261962
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
Core G: University of Kentucky Alzheimer's Disease Core Center
核心 G:肯塔基大学阿尔茨海默病核心中心
  • 批准号:
    10459472
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
University of Kentucky Alzheimer's Disease Research Center
肯塔基大学阿尔茨海默病研究中心
  • 批准号:
    10459464
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:
University of Kentucky Alzheimer's Disease Research Center
肯塔基大学阿尔茨海默病研究中心
  • 批准号:
    10261961
  • 财政年份:
    2021
  • 资助金额:
    $ 12.01万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了